For example, using TSA to induce chromatin remodeling at the LTR promoter is a clinical strategy to reactivate latent HIV reservoirs to clear the infection [4], and this has been found to synergize with TNF and other NF-κB activators [4,83,84]. The gene discussed is NFKB1; the disease is infection.